U S Physical Therapy Inc (USPH) stock
USPHNYSEServices-Health ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3022% above fair value
$99.60+1.00 (+1.01%)
Close on Nov 13, 2026Market cap $1.49BP/E –Yield 1.81%
U S Physical Therapy r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for U S Physical Therapy
U S Physical Therapy has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?